Clinical Nuclear Medicine

Skip Navigation LinksHome > July 2013 - Volume 38 - Issue 7 > 18F-FDG PET/CT Metabolic Activity Assessment in Infective an...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e318292aa17
Interesting Images

18F-FDG PET/CT Metabolic Activity Assessment in Infective and Neoplastic Diseases: A Patient With Systemic Hydatidosis and Concomitant Burkitt Lymphoma

Asabella, Artor Niccoli PhD*; Altini, Corinna MD*; Pisani, Antonio Rosario MD*; Ingravallo, Giuseppe PhD; Rubini, Giuseppe PhD*

Collapse Box


Abstract: We report a case of a 73-year-old-man with systemic hydatidosis and concomitant Burkitt lymphoma. He came at our attention for fever and weight loss suspected for parasitic cyst discharge and also for lymphoproliferative disorder. We performed US, which showed disseminated parasitic cysts. CECT showed parasitic cysts and also several abdominal and thoracic lymphnodes and adrenal hypodense tissue. 18F-FDG PET/CT was performed and showed lack of 18F-FDG uptake in cysts and high 18F-FDG uptake in lymphnodes and adrenal glands. These findings permitted us to exclude the cyst discharge, to localize a site for biopsy, and to define and stage the Burkitt lymphoma.

© 2013 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.